We are live on ! Find out more
REGN icon

Regeneron Pharmaceuticals
REGN

371 hedge funds and large institutions have $17B invested in Regeneron Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 371 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more call options, than puts

Call options by funds: $300M | Put options by funds: $263M

Holders
371
Holders Change
+371
Holders Change %
–
% of All Funds
12.11%
Holding in Top 10
9
Holding in Top 10 Change
+9
Holding in Top 10 Change %
% of All Funds
0.29%
New
371
Increased
–
Reduced
–
Closed
–
Calls
$300M
Puts
$263M
Net Calls
+$37.1M
Net Calls Change
+$37.1M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MTB
76
Mizuho Trust & Banking
Japan
$23.6M +$24.4M +104,924 New
Allianz Asset Management
77
Allianz Asset Management
Germany
$22.6M +$23.4M +100,423 New
Prudential Financial
78
Prudential Financial
New Jersey
$22.2M +$22.9M +98,519 New
TA
79
Teachers Advisors
New York
$21.4M +$22.1M +95,038 New
N
80
Nuveen
North Carolina
$21.4M +$22.1M +94,942 New
Axa
81
Axa
France
$21.3M +$22M +94,493 New
Principal Financial Group
82
Principal Financial Group
Iowa
$21M +$21.8M +93,512 New
APG Asset Management
83
APG Asset Management
Netherlands
$20.7M +$21.5M +92,138 New
HI
84
HBK Investments
Texas
$20.7M +$21.4M +92,100 New
BJ
85
BlackRock Japan
Japan
$20.5M +$21.2M +91,220 New
Citigroup
86
Citigroup
New York
$20M +$20.7M +89,001 New
VAM
87
Visium Asset Management
New York
$18.6M +$19.3M +82,929 New
QBFM
88
QS Batterymarch Financial Management
New York
$18.3M +$19M +81,396 New
Swiss National Bank
89
Swiss National Bank
Switzerland
$18.3M +$18.9M +81,200 New
Manulife (Manufacturers Life Insurance)
90
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$18.1M +$18.7M +80,485 New
Ohio Public Employees Retirement System (OPERS)
91
Ohio Public Employees Retirement System (OPERS)
Ohio
$18M +$18.6M +79,876 New
GLRA
92
Gerald L. Ray & Associates
Texas
$15.9M +$16.4M +70,490 New
U
93
UBS
Switzerland
$15.3M +$15.8M +67,829 New
BNP Paribas Financial Markets
94
BNP Paribas Financial Markets
France
$15M +$15.5M +66,597 New
State of Wisconsin Investment Board
95
State of Wisconsin Investment Board
Wisconsin
$14.3M +$14.8M +63,460 New
Federated Hermes
96
Federated Hermes
Pennsylvania
$14.1M +$14.6M +62,902 New
Zurich Cantonal Bank
97
Zurich Cantonal Bank
Switzerland
$13.9M +$14.4M +61,659 New
RG
98
Redmile Group
California
$13.7M +$14.2M +61,000 New
VanEck Associates
99
VanEck Associates
New York
$13.7M +$14.1M +60,743 New
SO
100
STRS Ohio
Ohio
$13.4M +$13.9M +59,636 New
2 3
4
5 6

REGN Hedge Fund Activity: Q2 2013 in Review

371 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Regeneron Pharmaceuticals (REGN) for Q2 2013, worth a combined $17B.

Buyers outnumbered sellers: 371 funds opened new REGN positions and 0 closed out — a net gain of 371 holders — while 0 added to existing stakes and 0 trimmed.

  • 371 institutional investors held Regeneron Pharmaceuticals (REGN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $17B of Regeneron Pharmaceuticals stock for Q2 2013.
  • 371 funds opened new Regeneron Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +371 holders.

Based on aggregated 13F filings for Q2 2013.